Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
ABNT
KANO, Eunice Kazue et al. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 1, p. 503-511, 2015Tradução . . Disponível em: https://doi.org/10.1590/S1984-82502015000100020. Acesso em: 17 nov. 2024.APA
Kano, E. K., Koono, E. E. M., Schramm, S. G., Serra, C. H. dos R., Abib Junior, E., Pereira, R., et al. (2015). Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers. Brazilian Journal of Pharmaceutical Sciences, 51( 1), 503-511. doi:10.1590/S1984-82502015000100020NLM
Kano EK, Koono EEM, Schramm SG, Serra CH dos R, Abib Junior E, Pereira R, Freitas MST, Iecco MC, Porta V. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 503-511.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/S1984-82502015000100020Vancouver
Kano EK, Koono EEM, Schramm SG, Serra CH dos R, Abib Junior E, Pereira R, Freitas MST, Iecco MC, Porta V. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 503-511.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/S1984-82502015000100020